Related Experiment Videos
Tumor necrosis factors.
1Division of Surgical Oncology, Brown University, Providence, Rhode Island.
Seminars in Surgical Oncology
|January 1, 1989
Summary
Tumor necrosis factor (TNF) is a cytokine with demonstrated anti-cancer properties, showing cytotoxic effects on various cancer cells and tumors. Further research combining TNF with other agents may reveal its full therapeutic potential in cancer treatment.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Tumor necrosis factor (TNF) is a cytokine produced by macrophages.
- TNF exhibits cytotoxic and cytostatic effects against various human cancer cell lines and tumors.
- TNF is associated with cachexia and is similar to cachectin.
Purpose of the Study:
- To explore the potential of Tumor necrosis factor (TNF) as an anti-cancer therapeutic agent.
- To investigate the mechanisms and synergistic effects of TNF in cancer treatment.
Main Methods:
- Characterization of TNF's molecular weight and gene location.
- Assessment of TNF's effects on Meth A sarcoma in Balb C mice.
- Evaluation of TNF's cytotoxicity on human cancer cell lines and tumors in nude mice.
- Analysis of TNF's interaction with chemotherapeutic agents and other cytokines (interferons, IL-2).
Main Results:
- TNF demonstrated necrosis of subcutaneous tumors and cytotoxic effects on cancer cell lines.
- TNF's genes are located on human chromosome 6.
- TNF's cytotoxic effects were amplified by pretreatment with chemotherapeutic agents and synergistic with certain interferons and IL-2.
- Initial clinical trials showed toxicity with minimal antitumor effects.
Conclusions:
- TNF possesses significant anti-tumor potential, acting via cytotoxic mechanisms.
- Combination therapies involving TNF with chemotherapy or biological agents may enhance its efficacy.
- Further clinical investigation is warranted to optimize TNF-based cancer therapies.